| 14.36 Data as of May 17 |  +0.31 / +2.21%Today’s Change | 9.65 Today|||52-Week Range 14.38 | +28.63% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $435.6M |
Company Description
Natus Medical, Inc. provides healthcare products. Its products include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The company's products are used for the screening, detecting, treating, monitoring and tracking of medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Natus was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in San Carlos, CA.
Employees
Shareholders
| Other institutional | 51.77% |
| Mutual fund holders | 29.77% |
| Individual stakeholders | 29.53% |
Top Executives
| John T. Buhler | President & Chief Operating Officer |
| James B. Hawkins, MBA | Chief Executive Officer & Director |
| Steven J. Murphy, CPA | CFO, Vice President & Head-Investor Relations |
| Ajay A. Bhave | Vice President-Global Engineering |
| D. Christopher Chung, MD | VP-Medical Affairs, Quality & Regulatory |
.
